CBS 2019
CBSMD教育中心
中 文

DAPT Duration

Abstract

Recommended Article

Osteoarthritis risk is reduced after treatment with ticagrelor compared to clopidogrel: a propensity score matching analysis Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Ticagrelor With or Without Aspirin After Complex PCI Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial Clopidogrel Pharmacogenetics: State-of-the-Art Review and the TAILOR-PCI Study Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)

Original Research2016 Dec;9(12).

JOURNAL:Circ Cardiovasc Interv. Article Link

Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome)

Prati F, Romagnoli E, Mintz GS et al. Keywords: acute coronary syndrome; percutaneous coronary intervention; prognosis; registries; stents

ABSTRACT